Published 23 October 2009, doi:10.1136/bmj.b3825
Cite this as: BMJ 2009;339:b3825

Editorials

Use of erythropoietins in patients with renal transplants

Normalisation of haemoglobin is hazardous, ineffective, and costly

The first 150 words of the full text of this article appear below.

In the United States, patients with renal transplants account for about 16% of all people who have a glomerular filtration rate of less than 30 ml/min (stage 4 chronic kidney disease) or who require renal replacement treatment.^{1 2} About 40% of patients with a kidney transplant have anaemia, and half of these are treated with erythropoietins.³ Management of anaemia in patients with a kidney transplant is complicated by their long history of renal disease, the inflammation associated with infection or rejection, and immunosuppressive medication.⁴

Compared with patients who have chronic kidney disease, kidney transplant recipients tend to be younger, more active, and less likely to have cardiovascular disease, although they may develop anaemia at a relatively higher glomerular filtration rate.³ Despite these differences, the linked study by Heinze and colleagues (doi:10.1136/bmj.b4018) indicates that the association between anaemia and mortality previously observed in other patients with low glomerular filtration rate . . . [Full text of this article]

¹ Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study

Georg Heinze, Alexander Kainz, Walter H Hörl, and Rainer Oberbauer
BMJ 2009 339: b4018. [Abstract] [Full Text] [PDF]

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
BMJ 1990 300: 573-578. [Abstract] [PDF]

Rapid Responses:

Read all Rapid Responses

Use of Erythropoietins

Rasheed Ahmad
bmj.com, 31 Oct 2009 [Full text]

Explanation for the U-curve in the plot of hazzard against haemoglobin.

Richard G Fiddian-Green
bmj.com, 1 Nov 2009 [Full text]

Anemia and kidney function are related

Jan Gossmann
bmj.com, 18 Nov 2009 [Full text]

‘Normalisation of haemoglobin is hazardous, ineffective and costly.’

Eric J Will
bmj.com, 23 Nov 2009 [Full text]

Online poll

Find out more on doc2doc >>